E-Beam Terminal Sterilized Powder • Preservative-Free Starting Material • Pharmaceutical-Grade Ingredients
Niagen At-Home Kit from Wells Pharmacy Network is prepared using an intentional formulation approach designed to support preparation consistency across patient care environments.
Niagen is prepared as a sterile powder using E-Beam terminal sterilization technology. Maintaining the formulation in powder form allows the starting material to remain preservative-free until preparation according to provider direction.
Formulation design may influence:
Niagen At-Home Kit includes bacteriostatic water supplied for reconstitution according to prescribing instructions.
Providing bacteriostatic water allows for consistent preparation across varied patient care environments.
Maintaining the formulation in powder form allows preparation closer to time of administration.
Materials Included in Kit:
(1) Nicotinamide Riboside Chloride (Niagen® Plus) Powder for Injection (500 mg vial)
(1) Bacteriostatic Water for Injection (30 mL vial)
Mixing Syringe (comes in two pieces):
– (1) 10 mL Mixing Syringe (without needle)
– (1) 22-Gauge Sterile Needle (do not use to administer subcutaneous injection)
(10) 1 mL Syringes (for administration use)
(20) Alcohol Prep Pads
Note: Your kit includes a 2-piece mixing syringe (10mL syringe + 22-gauge needle) for reconstitution, plus 10 separate 1mL syringes for injections. This video shows the reconstitution process only—individual injection technique is not demonstrated.
BUD Begins at Reconstitution
Because the formulation is not mixed until preparation, beyond-use dating begins at reconstitution.
When prepared according to prescribing instructions, this allows a 270-day BUD. Potential advantages may include:
Detailed Preparation Steps:
1. Thoroughly wash hands using soap and hot water. Dry hands completely.
2. Remove the plastic safety cap from one vial.
3. Using an alcohol prep pad, thoroughly wipe the rubber stopper.
4. Repeat steps 2-3 on the second vial.
5. Attach the 22-Gauge Sterile Needle to the 10mL Mixing Syringe to assemble the Mixing Syringe.
6. Using the Mixing Syringe, draw the volume of bacteriostatic water indicated in the Table in your written instructions, according to the concentration prescribed by your health care provider.
IMPORTANT: Do not reconstitute Niagen® Plus Sterile Powder with less than 5mL of bacteriostatic water.
7. Inject the prescribed volume of bacteriostatic water from the Mixing Syringe into the Nicotinamide Riboside Chloride (Niagen® Plus) Powder for Injection 500mg vial.
8. Remove the Mixing Syringe and gently swirl the vial until the powder dissolves completely.
IMPORTANT: Discard the Mixing Syringe needle in a Sharps Container. Review your state/city regulations on safe needle disposal or consult your prescriber.
9. Verify the solution is clear, colorless, and free of particulates before use.
10. Refrigerate the reconstituted solution and store refrigerated between injections.
11. Discard any remaining contents after the 28-day beyond-use date.
Coming Soon
Powder formulation may support shipment without cold-chain requirements. Potential advantages may include:
• Simplified shipping logistics
• Reduced cold chain risk
• Rlexible storage conditions prior to preparation
Frequently Asked Questions
Bacteriostatic water is supplied with the kit for reconstitution according to prescribing instructions.
The powder formulation contains no preservatives prior to reconstitution.
Beyond-use dating begins once the product is reconstituted according to prescribing instructions.
In addition to other screening parameters, consideration should be given to patients with the following conditions:
• Liver disease
• Kidney disease
• Prior diagnoses, including any form of cancer
• An unusual or allergic reaction to NR, NAD+, or other forms of vitamin B3
• Pregnant or trying to get pregnant
• Breast-feeding
The use of Niagen® Plus in children has not been studied; therefore, its use in children is not recommended.
At this time, NIAGEN® Plus has not been shown to interact with any medications. However, if an adverse reaction is observed, it is important to obtain a list of all prescription and over the counter medications, herbs, non-prescription drugs, or dietary supplements currently in use by the patient.
Though the following have been observed in one or more individuals, each individual is unique and such experiences may or may not be experienced by the patient. The following side effects have been observed in participants who were prescribed NIAGEN® Plus:
• Pain or discomfort (including a change in temperature) at the site of the injection.
• Infection at the site of the injection.
• Tingling to the face, extremities, or throughout the body
• Mild gastrointestinal disturbance, including nausea
• Tension in the muscles of the face
• Headache
• Sinus pressure
• Discomfort localized in areas of the body where issues may have been previously observed
• Change in energy level
This list may not describe all possible side effects.
Side effects from NIAGEN® Plus usually will resolve on their own. However, please seek medical attention for side effects that persist or are bothersome.
To report side effects of any drug, contact FDA’s toll-free information line, 1-888-INFO-FDA (1-888-463-6332). Press 2 to report into MedWatch or to receive instructions.
Store unopened vial in powder form and reconstituted material for further use at refrigerated temperature (2°C – 8°C / 35°F – 46°F).
If any of the following occur during therapy, discontinue use of NIAGEN® Plus, symptomatically treat, or seek immediate medical attention.
• Fever exceeding 101°F within 72 hours of receiving the injection
• Abnormal heart arrhythmia (spelling was wrong)
• Persistent diarrhea or vomiting
• Fainting or dizziness
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Please consult your healthcare provider for information and prescription information. Beyond-use dating determined according to USP guidelines and prescribing instructions.
References: A recent medRxiv pilot clinical study (June 2024) compared Niagen®+ IV and NAD+ IV in healthy adults, highlighting emerging data on NAD+ restoration and optimization. View study.
Let us be your compounding pharmacy of choice
Ask your physician about Wells Pharmacy Network today for all of your compounding needs. If we haven’t yet made their acquaintance, let us know and we’ll be happy to have one of our Customized Medication Specialists contact them to discuss how our commitment to superior science and service makes us a leading compounding pharmacy capable of preparing custom medications that meet their requirements.
Patients with questions about an order, prescription, or medication, please call (866) 506-2174 and ask to speak to a pharmacist.
Contact Us
Main Phone: (866) 506-2174
Prescription Fax Line: (352) 401-5650
